156 related articles for article (PubMed ID: 35255710)
1. Therapeutic and Prognostic Significance of Arachidonic Acid in Heart Failure.
Ma K; Yang J; Shao Y; Li P; Guo H; Wu J; Zhu Y; Zhang H; Zhang X; Du J; Li Y
Circ Res; 2022 Apr; 130(7):1056-1071. PubMed ID: 35255710
[TBL] [Abstract][Full Text] [Related]
2. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
4. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of the Get With The Guidelines Heart Failure Risk Score in Unselected Cardiac Intensive Care Unit Patients.
Lyle M; Wan SH; Murphree D; Bennett C; Wiley BM; Barsness G; Redfield M; Jentzer J
J Am Heart Assoc; 2020 Feb; 9(3):e012439. PubMed ID: 31986993
[TBL] [Abstract][Full Text] [Related]
6. External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.
Salah K; Stienen S; Moons AHM; Bakx ALM; van Pol PE; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayes-Genis A; Pinto YM; Tijssen JG; Kok WE
J Am Heart Assoc; 2019 Jul; 8(14):e010309. PubMed ID: 31296084
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.
Noveanu M; Breidthardt T; Potocki M; Reichlin T; Twerenbold R; Uthoff H; Socrates T; Arenja N; Reiter M; Meissner J; Heinisch C; Stalder S; Mueller C
Crit Care; 2011; 15(1):R1. PubMed ID: 21208408
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
[TBL] [Abstract][Full Text] [Related]
9. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.
Kociol RD; Horton JR; Fonarow GC; Reyes EM; Shaw LK; O'Connor CM; Felker GM; Hernandez AF
Circ Heart Fail; 2011 Sep; 4(5):628-36. PubMed ID: 21743005
[TBL] [Abstract][Full Text] [Related]
10. Predicting short-term mortality in advanced decompensated heart failure - role of the updated acute decompensated heart failure/N-terminal pro-B-type natriuretic Peptide risk score.
Scrutinio D; Ammirati E; Passantino A; Guida P; D'Angelo L; Oliva F; Ciccone MM; Iacoviello M; Dentamaro I; Santoro D; Lagioia R; Sarzi Braga S; Guzzetti D; Frigerio M
Circ J; 2015; 79(5):1076-83. PubMed ID: 25753469
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
12. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
deFilippi CR; Seliger SL; Maynard S; Christenson RH
Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
[TBL] [Abstract][Full Text] [Related]
13. Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
Misumi K; Matsue Y; Nogi K; Fujimoto Y; Kagiyama N; Kasai T; Kitai T; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kida K; Okumura T; Nogi M; Ishihara S; Ueda T; Kawakami R; Saito Y; Minamino T
J Cardiol; 2023 Jun; 81(6):531-536. PubMed ID: 36858175
[TBL] [Abstract][Full Text] [Related]
14. Associations With Eicosapentaenoic Acid to Arachidonic Acid Ratio and Mortality in Hospitalized Heart Failure Patients.
Watanabe S; Yoshihisa A; Kanno Y; Takiguchi M; Yokokawa T; Sato A; Miura S; Shimizu T; Abe S; Sato T; Suzuki S; Oikawa M; Sakamoto N; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
J Card Fail; 2016 Dec; 22(12):962-969. PubMed ID: 27138463
[TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction.
Rich JD; Burns J; Freed BH; Maurer MS; Burkhoff D; Shah SJ
J Am Heart Assoc; 2018 Oct; 7(20):e009594. PubMed ID: 30371285
[TBL] [Abstract][Full Text] [Related]
16. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
17. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
[TBL] [Abstract][Full Text] [Related]
18. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
[TBL] [Abstract][Full Text] [Related]
19. Machine learning-based model for predicting 1 year mortality of hospitalized patients with heart failure.
Tohyama T; Ide T; Ikeda M; Kaku H; Enzan N; Matsushima S; Funakoshi K; Kishimoto J; Todaka K; Tsutsui H
ESC Heart Fail; 2021 Oct; 8(5):4077-4085. PubMed ID: 34390311
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.
Lim NK; Lee SE; Lee HY; Cho HJ; Choe WS; Kim H; Choi JO; Jeon ES; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Oh BH; Park HY
J Cardiol; 2019 Feb; 73(2):108-113. PubMed ID: 30360893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
